NEW YORK (GenomeWeb News) – Hologic announced today that the US Food and Drug Administration has cleared for marketing the firm's Aprima Trichomonas vaginalis Assay to run on the Panther System.

The assay was previously cleared by the FDA for use on Gen-Probe's Tigris System in April 2011. According to Bedford, Mass.-based Hologic, the assay remains the only FDA-cleared amplified nucleic acid test on the market for detecting Trichomonas.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.